Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019
Selma Ugurel, Joachim Röhmel, Paolo A. Ascierto, Jürgen C. Becker, Keith T. Flaherty, Jean‐Jacques Grob, Axel Hauschild, James Larkin, Elisabeth Livingstone, Georgina V. Long, Paul Lorigan, Grant A. McArthur, Antoni Ribas, Caroline Robert, Lisa Zimmer, Dirk Schadendorf, Claus Garbe
Topics & Concepts
MedicineOncologyMelanomaBlockadeClinical trialInternal medicineSurvival analysisProgression-free survivalMEK inhibitorKinaseCancer researchOverall survivalMAPK/ERK pathwayBiologyReceptorCell biologyMelanoma and MAPK PathwaysCancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management